Waltham biotech raises $110 million for gene therapy treatments

Affinia Therapeutics, a Waltham-based biotech working on gene therapies to treat diseases using technology developed at Massachusetts Eye and Ear, said Monday it has raised $110 million in a new venture capital round.

Waltham biotech raises $110 million for gene therapy treatments